Transcatheter aortic valve implantation: a single-center experience of 300 cases.
Ariel Finkelstein(Tel Aviv Sourasky Medical Center), Shmuel Banai, Eran Leshem‐Rubinow(Tel Aviv University), Simon Biner, Shmuel Bazan(Tel Aviv University), Edo Y. Birati(Bar-Ilan University), Arie Steinvil(Tel Aviv University), Yaron Arbel, Yigal Abramowitz(University of Zurich), Yanai Ben Gal(Tel Aviv University), Nechama Sheinberg, Gad Keren(Assuta Medical Center), Eyal Ben–Assa(Massachusetts General Hospital), Amir Halkin(Tel Aviv University)
PubMed
October 1, 2013
Cited by 18
Related Papers
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations
|Journal of the American College of Cardiology|2000|731
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study
|Journal of the American College of Cardiology|2001|646
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
|Journal of the American College of Cardiology|2017|486
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography
|Atherosclerosis|2012|390
Role of Naturally Occurring CD4 <sup>+</sup> CD25 <sup>+</sup> Regulatory T Cells in Experimental Atherosclerosis
|Arteriosclerosis Thrombosis and Vascular Biology|2007|347